If you're a healthcare professional concerned about antimicrobial resistance (AMR), this working paper by Fernando and McKibbin offers a compelling economic case for action.
Wastewater-based epidemiology (WBE) is emerging as a transformative tool in antimicrobial resistance (AMR) surveillance, enabling early detection of pathogen trends at the community level — even among asymptomatic individuals and those outside the healthcare system.
Today's technology, including decision support systems (DSS), real-time analytics, and artificial intelligence (AI) tools, are reshaping infection prevention/management and antimicrobial stewardship.
Blood culture contamination remains a persistent challenge in healthcare, impacting patient care and outcomes, and driving up costs. As awareness grows, blood culture kitting has emerged as a practical solution to improve sample collection by standardizing supplies, simplifying decision-making, and reducing waste.
Antimicrobial stewardship (AMS) metrics are essential for identifying, acting on, and re-evaluating opportunities to enhance the safe and appropriate use of antibiotics. Without reliable data, antibiotic stewards risk being ineffective.
It’s been five years since the World Health Organization (WHO) declared COVID-19 a pandemic in March 2020. This global health crisis fundamentally reshaped clinical laboratories, accelerating advancements in diagnostic testing capabilities, capacity, and automation.
A recent survey by bioMérieux and The UK Sepsis Trust found that while 95% of clinicians identify sepsis as a serious condition, 66% agree there is sometimes a delay in diagnosis in the hospital where they work.
Explore the systemic impacts of antimicrobial resistance (AMR) and the importance of implementing effective antimicrobial stewardship (AMS) strategies in this easy to understand infographic.
A recent retrospective study examining sepsis treatment in patients with and without pulmonary arterial hypertension (PAH) reveals critical insights for clinical practice.
Antimicrobial resistance in Pseudomonas aeruginosa remains a serious health threat because multiple mechanisms may be involved that further complicate the management of infections.
With the landscape of healthcare rapidly evolving, diagnostic innovation, health equity, and the strategic value of laboratory services are emerging as critical focal points.
Did you know that over 5 million people are affected by meningitis every year, and around half of all meningitis deaths are in children under 5 years old?
In recognition of World AMR Awareness Week (WAAW), this Viewpoints Series interview with pharmacist Jacob Morton explores the critical issue of limited public awareness about antimicrobial resistance (AMR) and its impact on patient healthcare.
Surgical-site infection (SSI) is one of the most common healthcare-associated infections (HAI) globally, and the most frequent postoperative complication
An observational study conducted in Canada and published in Critical Care reveals significant financial implications of sepsis on post-hospitalization patient care.
Did you know that Hospital Acquired Pneumonia (HAP) is the second most common nosocomial infection and accounts for more than 50% of the antibiotics prescribed?
Did you know that elderly people are at higher risk of having acute bacterial meningitis associated with an earlier and higher mortality rate than in younger patients ?
Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!
In this MLO feature article, Chris Groke, Senior Medical Science Liaison at bioMérieux, breaks down the history of diagnostic innovation in the fight against antimicrobial resistance (AMR). As a Board-Certified Infectious Diseases Pharmacist, Groke shares knowledge and insight into the evolution of AMR and the critical role diagnostics play in addressing this global public health threat.
Fifty-two medical specialty organizations and associations from across India are taking on antimicrobial resistance (AMR), paving the way for low- to middle-income countries looking to mitigate the impact of AMR. The country recognizes the severe impact caused by neglecting AMR, with over a million deaths attributed to AMR-related complications each year.
The antimicrobial stewardship (AMS) landscape is rapidly changing and diagnostics are revolutionizing how medical professionals meet AMS goals. In this CIDRAP ASP webinar and roundtable, experts discuss insights and share personal experiences regarding diagnostic trends and emerging opportunities for AMS.
Did you know that bacterial arthritis is most common cause of pediatric septic arthritis in children with an incidence of 1-37 cases per 100,000 worldwide?
This groundbreaking study by Fernando and McKibbin employs sophisticated macroeconomic modeling to assess the global economic impacts of antimicrobial resistance (AMR) across G20 countries
A retrospective analysis of 382,149 Staphylococcus aureus isolates from U.S. Veterans Health Administration outpatients reveals significant shifts in antimicrobial resistance patterns over a 10-year period.
Discover a clinical case illustrating how rapid multiplex PCR can support patient management and treatment in the context of a patient suffering from COVID-19 in the context of a co-infection with Aspergillus
As part of a CIDRAP three-part webinar series, bioMérieux is proud to support this second installment that explores the shifting landscape of the rapid diagnostic laboratory, highlighting the transformative impact brought about by new technologies.
Discover a clinical case from Dr Naim Aoun highlighting the instrumental role of syndromic testing in managing critically ill patient within the intensive care unit.
A study shows source-specific antibiotic order sets in emergency care improve empiric treatment decisions for sepsis and support timely patient management.
Did you know that Hospital Acquired Pneumonia is the second most common nosocomial infection and accounts for more than 50% of the antibiotics prescribed?
The Sepsis Alliance AMR Virtual Conference explores innovative solutions and educational initiatives for managing sepsis and combating antimicrobial resistance.
Did you know that Hospital Acquired Pneumonia is the second most common nosocomial infection and accounts for more than 50% of the antibiotics prescribed?
bioMérieux experts discuss how microbial identification and susceptibility testing can enhance antimicrobial stewardship and improve patient outcomes post-COVID.
A study from The University of Manchester highlights how socioeconomic factors increase mortality risk in non-COVID sepsis, stressing targeted prevention.
EHR-based data shows SARS-CoV-2–associated sepsis was more severe and frequent than bacterial sepsis early in the pandemic, highlighting tracking gaps.
Read about how ribosome-binding antibiotics can enhance bacterial longevity and growth efficiency, challenging traditional views on antibiotic resistance.
Discover key reasons why pharmacies and labs should collaborate to enhance healthcare services, address provider shortages, and improve patient outcomes.
A new study with the UK Sepsis Trust explores barriers to sepsis care bundle adherence in Europe and offers insights to improve sepsis management strategies.
This briefing explores how outcomes research can highlight the value of rapid diagnostics in combating antimicrobial resistance and supporting antimicrobial stewardship
Learn about a study on antimicrobial resistance in post-traumatic wound infections in Uganda and the need for routine microbial diagnostics to guide treatment decisions.
Explore the growing threat of fungal infections in AMR, highlighting the challenges of detection, resistance, and the shortage of trained clinical mycologists.
Research reveals that the HLA-B*15:01 allele may be linked to asymptomatic COVID-19 infection, potentially due to pre-existing T-cell immunity from previous coronaviruses.
Explore how artificial intelligence and machine learning are advancing the fight against infectious diseases, aiding in drug discovery, diagnostics, and outbreak control.
Download the policy brief on the WHO’s Global Research Agenda for AMR in human health, outlining top research priorities to combat antimicrobial resistance by 2030.
Results from the Society of Critical Care Medicine Discovery VIRUS international COVID-19 Registry aim to determine the rate and factors associated with early empiric antibiotic (EEAB) treatment to help set goals for antimicrobial stewardship efforts, in the post-pandemic era.
An antimicrobial stewardship program at An-Najah National University Hospital significantly reduced antibiotic use and costs, according to a recent study.
A study in Cameroon highlights rising sepsis cases and AMR, emphasizing the need for surveillance, infection control, and antibiotic stewardship in hospitals.
A clinical trial in West Africa tests whether intrapartum azithromycin reduces neonatal sepsis and mortality, with additional evaluation of infection and fever rates.
Chile uses cloud-based analytics to enhance antimicrobial stewardship by combining AMR data from over 40 hospitals for better patient and population outcomes.
A review of 148 studies links COVID-19 hospital surges to rising antimicrobial resistance, with 60.8% of bacterial co-infections resistant to treatment.
According to predictions from professor and practicing intensivist, Dr. Hannah Wunsch, war, multidrug resistance, climate change, emerging diseases, and reduced confidence in vaccination will be among the factors that influence an expected increase in infectious diseases in the ICU.
Rapid diagnostics help optimize antimicrobial stewardship for respiratory infections by identifying pathogens quickly, guiding treatment, and reducing AMR risks.
This study highlights the effectiveness of the VITEK® 2 AES in providing rapid, accurate antimicrobial susceptibility testing for Enterobacterales isolates.
Global antimicrobial resistance (AMR) — the “silent pandemic” — is already causing a significant burden on healthcare systems, with COVID-19 only adding to the complexity and challenge of this global public health threat.
In this article, Brian Raux, PharmD, discusses the global impact COVID-19 has had on the rise of antimicrobial resistance (AMR) and the alarming increase of hospital-acquired infections (HAI).
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota interviewed Christian Lillis, founder of the Peggy Lillis Foundation, about the fight against Clostridioides difficile through education, awareness, and reducing unnecessary antibiotic use.
Explore a study on the severity of COVID-19 in infants under 3 months, comparing symptoms, outcomes, and antimicrobial stewardship approaches in this vulnerable group
Study reveals that inflammatory proteins in COVID-19 patients' blood may disrupt neurogenesis, leading to cognitive symptoms like delirium and memory loss.
A group of global experts from Italy, Lebanon, Thailand, India, the U.S., Colombia and China speak about the need for rapid diagnostic tests and efficient laboratory workflows for multi-drug resistant (MDR) Gram-negative infections.
Researchers around the world worked together to identify educational gaps and systemic barriers obstructing adherence to antimicrobial stewardship (AMS) principles in France, India, Mexico, and the United States.
Superbugs are worsening neonatal sepsis outcomes in South Asia where antibiotic resistance is driving high mortality rates in newborns with severe infections.
The CDC's 2022 special report reveals a rise in multi-drug resistant organisms (MDROs) in U.S. hospitals during COVID-19, highlighting the impact of increased antimicrobial use.
Researchers at TISH in Ethiopia used bioMérieux AST to study Gram-negative BSIs, finding high AMR rates in pediatric and ICU patients, urging intervention.
-Panel?qlt=85&wid=1024&ts=1762376382757&dpr=off)
